Cancer research in space for life on earth

Cancer research in space for life on earth
by Clarence Oxford
Los Angeles CA (SPX) Sep 06, 2024
Los Angeles CA (SPX) Sep 06, 2024 - The Wake Forest Institute for Regenerative Medicine (WFIRM) has been selected to participate in a major cancer research project aboard the International Space Station (ISS). The project, one of five chosen through a competitive process by the ISS National Lab in collaboration with NASA, is set to investigate how microgravity influences cancer development and treatment.

Leading the project is Dr. Shay Soker, who will focus on the use of organoids, which are lab-grown miniature versions of organs derived from cells of colorectal cancer patients. These organoids will be sent to the ISS, where the effects of microgravity on cancer growth and its responsiveness to treatments will be studied. The research aims to deliver breakthroughs that could improve cancer therapies on Earth.

"Being selected for this project is an incredible honor and opportunity for our team at WFIRM," said Dr. Soker. "The microgravity environment of the ISS provides a unique setting to study cancer in ways that are not possible on Earth. This research has the potential to unlock new understandings of cancer behavior and lead to more effective treatments."

The ISS National Lab, in partnership with NASA, is committed to leveraging space-based research to advance life sciences and improve conditions on Earth. The selected projects are considered cutting-edge in the field of scientific exploration, aiming to push the boundaries of cancer research.

"This selection underscores WFIRM's commitment to pushing the boundaries of scientific research and finding innovative solutions to some of the world's most challenging health issues," said Dr. Anthony Atala, Director of Wake Forest Institute for Regenerative Medicine and co-lead for the grant. "Conducting this research in the microgravity environment of the ISS offers us a rare opportunity to gain a deeper understanding of cancer, with the ultimate goal of improving patient outcomes here on Earth."

The research has broad potential beyond the space station, as scientists hope to discover new disease progression mechanisms and identify new therapeutic targets. The study's findings could lead to more effective cancer treatments and improved outcomes for patients worldwide.

This project is part of a larger initiative by the ISS National Lab and NASA to utilize space's unique environment for scientific innovation. The partnership highlights the critical role space research plays in addressing humanity's greatest challenges.

WFIRM will continue to provide updates on the project's progress and its potential impact on the future of cancer treatments.